UCB’s James Musick on embracing digital therapeutics
Digital has rapidly taken over the pharma industry, but many still don’t fully understand how to harness it. Paul Tunnah spoke to James Musick, UCB’s head of digital transformation, at JP Morgan to get his views on the factors companies most commonly miss and how they can be truly successful with digital therapeutics.
About the interviewee
Dr James Musick is VP and head of digital transformation at UCB Biopharma where he is responsible for helping UCB improve lives of people living with severe disease by applying new digital technologies in various ways to the existing healthcare ecosystem. Prior to joining UCB, Dr Musick was at Novartis leading the Digital Medicines Commercial team.